Anthony Sebba
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 21
- Systemic Lupus Erythematosus Research 6
-
- Bone health and osteoporosis research 14
- Bone and Joint Diseases 7
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 7
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 4
- Oncology top 5%
- Bone health and treatments 13
-
- Bone Metabolism and Diseases 6
- Co-authors
- Juan J. Gómez‐ReinoGraeme JonesM. C. GenoveseJianhui GuMatija TomšičAndrea CalvoMitchell B. LowensteinDaniel Siri
- Journals
- Annals of the Rheumatic Diseases (7 papers)Lara D. Veeken (4 papers)Clinical Rheumatology (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Anthony Sebba
37 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Rheumatology 973
- Orthopedics and Sports Medicine 387
- Hematology 456
- Immunology 397
- Oncology 493
Countries citing papers authored by Anthony Sebba
This map shows the geographic impact of Anthony Sebba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Sebba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Sebba more than expected).
Fields of papers citing papers by Anthony Sebba
This network shows the impact of papers produced by Anthony Sebba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Sebba. The network helps show where Anthony Sebba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anthony Sebba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 51 | |
| 4 | 2020 | 27 | |
| 5 | 2016 | 29 | |
| 6 | 2013 | 42 | |
| 7 | 2013 | 106 | |
| 8 | 2012 | 6 | |
| 9 | 2011 | 114 | |
| 10 | Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studybreakdown → | 2009 | 609 |
| 11 | 2009 | 75 | |
| 12 | 2008 | 36 | |
| 13 | 2008 | 18 | |
| 14 | 2008 | 6 | |
| 15 | 2008 | 13 | |
| 16 | 2006 | 5 | |
| 17 | 2006 | 94 | |
| 18 | 2006 | 105 | |
| 19 | 2004 | 44 | |
| 20 | Alendronate for Osteoporosis | 2001 | 1 |
About Anthony Sebba
Anthony Sebba is a scholar working on Orthopedics and Sports Medicine, Rheumatology and Hematology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Bone health and osteoporosis research (14 papers), Bone health and treatments (13 papers), Bone and Joint Diseases (7 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Systemic Lupus Erythematosus Research (6 papers), Bone Metabolism and Diseases (6 papers) and Biosimilars and Bioanalytical Methods (4 papers). The work is most often cited by research in Rheumatology (973 citations), Orthopedics and Sports Medicine (387 citations) and Hematology (456 citations). Anthony Sebba has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Juan J. Gómez‐Reino, Graeme Jones, M. C. Genovese, Jianhui Gu, Matija Tomšič, Andrea Calvo, Mitchell B. Lowenstein, Daniel Siri, Thasia Woodworth and Emma Alecock. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Clinical Rheumatology, The Journal of Rheumatology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.